Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Borderlines types of multiple sclerosis].

J De Seze1

  • 1Clinique Neurologique, Hôpital Civil, Strasbourg. jerome.de.seze@chru-strasbourg.fr

Revue Neurologique
|February 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Revue neurologique·2025
Same author

Teriflunomide, cognition and MRI: A longitudinal study.

Multiple sclerosis and related disorders·2024
Same author

Clinical applications of deep learning in neuroinflammatory diseases: A scoping review.

Revue neurologique·2024
Same author

A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study.

Revue neurologique·2023
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
Same journal

Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective.

Revue neurologique·2026
See all related articles

Multiple sclerosis (MS) presents with diverse variants, including pseudo-tumoral and demographic types. This review explores these forms and related disorders, aiding differential diagnosis with other autoimmune conditions.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with an unknown etiology.
  • Various atypical presentations and related conditions complicate MS diagnosis.
  • Understanding MS variants is crucial for accurate patient management.

Purpose of the Study:

  • To review and delineate pseudo-tumoral variants of MS, including Balo's, Marburg's, and Schilder's forms.
  • To discuss demographic variants such as young and elderly onset MS.
  • To explore differential diagnoses with related neurological disorders and autoimmune diseases.

Main Methods:

  • Literature review of pseudo-tumoral and demographic variants of MS.
  • Analysis of related neurological disorders: neuromyelitis optica and acute demyelinating encephalomyelitis.

Related Experiment Videos

  • Discussion of differential diagnostic criteria for MS and other autoimmune conditions.

    • Main Results:

    • Detailed description of Balo's, Marburg's, and Schilder's MS variants.
    • Characterization of early-onset and late-onset MS.
    • Identification of key differentiating features between MS and conditions like neuromyelitis optica.

    Conclusions:

    • MS exhibits a broad spectrum of clinical presentations beyond typical forms.
    • Recognizing pseudo-tumoral and demographic variants improves diagnostic accuracy.
    • Distinguishing MS from related autoimmune disorders is essential for appropriate treatment strategies.